Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reprobiol is a Belgian biotechnology company specializing in the development and production of hormones and reagents for animal reproduction. Founded as a spin-off from the University of Liège, the company focuses on improving fertility and reproductive management in livestock such as cattle, sheep, and horses. Their product portfolio includes equine Chorionic Gonadotropin (eCG/PMSG) and various monoclonal antibodies used in veterinary diagnostics and research. Reprobiol provides both natural and recombinant hormonal solutions to the global veterinary pharmaceutical market. The company also offers specialized laboratory services for hormone quantification and reproductive monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reprobiol.